The 24-h FEV(1) time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2–4 COPD: results from two 6-week crossover studies

ABSTRACT: These studies evaluated the 24-h forced expiratory volume in 1 sec (FEV(1)) profile of once-daily (QD) olodaterol compared to placebo and twice-daily (BID) formoterol in patients with moderate to very severe chronic obstructive pulmonary disease. In two replicate, randomized, double-blind,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Feldman, Gregory J, Bernstein, Jonathan A, Hamilton, Alan, Nivens, Michael C, Korducki, Lawrence, LaForce, Craig
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4152473/
https://ncbi.nlm.nih.gov/pubmed/25187881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-419
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados